|
DIP2C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.898650E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.976800E-01 |
| Normal-vs-Stage2 |
3.346400E-01 |
| Normal-vs-Stage3 |
2.075800E-03 |
| Normal-vs-Stage4 |
2.284300E-02 |
| Stage1-vs-Stage2 |
2.376400E-01 |
| Stage1-vs-Stage3 |
2.22789999999584E-05 |
| Stage1-vs-Stage4 |
7.299100E-03 |
| Stage2-vs-Stage3 |
7.058400E-02 |
| Stage2-vs-Stage4 |
1.579620E-01 |
| Stage3-vs-Stage4 |
9.050600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.238000E-01 |
| Normal-vs-AfricanAmerican |
8.952300E-02 |
| Normal-vs-Asian |
9.140400E-01 |
| Caucasian-vs-AfricanAmerican |
4.010600E-01 |
| Caucasian-vs-Asian |
7.042200E-01 |
| AfricanAmerican-vs-Asian |
5.671600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.200300E-02 |
| Normal-vs-Female |
9.910200E-01 |
| Male-vs-Female |
9.898400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.898200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.984800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.730500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.653800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.663180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.878000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.242400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.245580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.939000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.941400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.546100E-02 |
| Normal-vs-Grade 2 |
9.240000E-01 |
| Normal-vs-Grade 3 |
2.306800E-01 |
| Normal-vs-Grade 4 |
3.50519999692267E-08 |
| Grade 1-vs-Grade 2 |
2.413900E-02 |
| Grade 1-vs-Grade 3 |
1.475540E-02 |
| Grade 1-vs-Grade 4 |
7.95080001836368E-10 |
| Grade 2-vs-Grade 3 |
1.480960E-01 |
| Grade 2-vs-Grade 4 |
1.68187686000465E-12 |
| Grade 3-vs-Grade 4 |
7.30339999588381E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.959800E-02 |
| Normal-vs-ccB subtype |
1.54199999999882E-05 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.159800E-01 |
| Normal-vs-N1 |
4.686200E-02 |
| N0-vs-N1 |
2.022800E-01 |
|
|
